dalteparin and dx 9065a

dalteparin has been researched along with dx 9065a in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Crain, EJ; Knabb, RM; Quan, ML; Watson, CA; Wexler, RR; Wong, PC	1
Badimon, JJ; Chen, J; Fuster, V; Kunitada, S; Osende, J; Robbins, J; Shimbo, D; Shimoto, Y	1
Harada, N; Okajima, K; Uchiba, M	1
Graff, J; Harder, S; Picard-Willems, B	1
Burghaus, R; Coboeken, K; Gaub, T; Kuepfer, L; Lippert, J; Mueck, W; Sensse, A; Siegmund, HU; Weiss, W	1

Trials

1 trial(s) available for dalteparin and dx 9065a

Article	Year
Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin. Thrombosis and haemostasis, 2002, Volume: 88, Issue:5 Topics: Adult; Aspirin; Blood Coagulation Tests; Cross-Over Studies; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorheology; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Naphthalenes; Propionates; Stress, Mechanical	2002

Article

Year

Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin.

Thrombosis and haemostasis, 2002, Volume: 88, Issue:5

Topics: Adult; Aspirin; Blood Coagulation Tests; Cross-Over Studies; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorheology; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Naphthalenes; Propionates; Stress, Mechanical

2002

Other Studies

4 other study(ies) available for dalteparin and dx 9065a

Article	Year
Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics. The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:1 Topics: Animals; Anticoagulants; Arteriovenous Shunt, Surgical; Blood Coagulation; Dalteparin; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; Humans; In Vitro Techniques; Isoxazoles; Male; Naphthalenes; Platelet Aggregation; Propionates; Rabbits; Recombinant Proteins; Sulfonamides; Tetrazoles; Thrombosis	2000
Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. Critical care medicine, 2006, Volume: 34, Issue:7 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anticoagulants; Calcium; Cyclooxygenase 2 Inhibitors; Dalteparin; Edema; Endothelium; Epoprostenol; Fibrin Fibrinogen Degradation Products; Heparin; In Vitro Techniques; Indomethacin; Inflammation; Interleukin-12; Leukocytes; Liver; Liver Diseases; Male; Monocytes; Naphthalenes; Nitrobenzenes; Peroxidase; Propionates; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Sulfonamides; Transaminases; Tumor Necrosis Factor-alpha	2006
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a. International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:4 Topics: Adult; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Daboia; Drug Monitoring; Enoxaparin; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; Naphthalenes; Partial Thromboplastin Time; Polysaccharides; Propionates; Thromboplastin; Viper Venoms	2007
Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation. PloS one, 2011, Apr-22, Volume: 6, Issue:4 Topics: Anticoagulants; Azetidines; Benzylamines; Blood Circulation; Blood Coagulation; Computer Simulation; Enoxaparin; Humans; Models, Biological; Morpholines; Naphthalenes; Partial Thromboplastin Time; Propionates; Rivaroxaban; Thiophenes; Translational Research, Biomedical; Treatment Outcome; Warfarin	2011